
Technopath Clinical Diagnostics
About Technopath Clinical Diagnostics
Technopath Clinical Diagnostics is a Healthcare company, and was acquired by LGC in February 2021. Quality control materials and informatics solutions for clinical diagnostics. It operates on a B2B and B2C model. Technopath Clinical Diagnostics offers products and services including Multichem QC and IAMQC Solutions. Its focus areas include Informatics, Software Solutions, Peer Reporting Systems and Clinical Diagnostics.
Company details
Technopath Clinical Diagnostics is identified as a global developer and manufacturer of quality control materials and software, primarily serving clinical laboratories. Products such as Multichem QC and IAMQC solutions are supplied to enhance laboratory efficiencies in areas like immunoassay and infectious disease testing. Partnerships with entities including Abbott and Northwell Health have been formed to distribute these solutions. Resources, including webinars and educational materials, are made available through the Knowledge Centre. Operations are conducted from locations in Ireland and the USA, focusing on meeting regulatory standards in diagnostics.
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website technopathclinicaldiagnostics.com
- Social LinkedIn
- Acquired by LGC (Feb 2021)
- Legal Name Technopath Clinical Diagnostics
Products & Services of Technopath Clinical Diagnostics
Technopath Clinical Diagnostics offers a comprehensive portfolio of products and services, including Multichem QC and IAMQC Solutions.
Quality control materials are supplied for various diagnostic tests, including high-sensitive troponin QC in a frozen liquid stable format
Software solutions are offered for peer reporting and quality control management in clinical laboratories
Funding Insights of Technopath Clinical Diagnostics
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Technopath Clinical Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2018 | Debt – Conventional | β | β |
2 investors in total: 2 institutional.
Investors in Technopath Clinical Diagnostics
Technopath Clinical Diagnostics has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include LGC and Proventus.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A family office is operated across Nordic and European regions. | proventus.se | Stockholm, Sweden | ||
Molecular biology reagents and services are supplied to biotech industries. | 1842 | lgcgroup.com | Teddington, United Kingdom |
Investor details for Technopath Clinical Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Technopath Clinical Diagnostics
2 dated milestones of Technopath Clinical Diagnostics across 3 years, from founding to its latest funding, stage changes and deals.
- Funding First funding round.
- Exit Acquired by LGC.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Technopath Clinical Diagnostics
Technopath Clinical Diagnostics is identified as a global developer and manufacturer of quality control materials and software, primarily serving clinical laboratories. Products such as Multichem QC and IAMQC solutions are supplied to enhance laboratory efficiencies in areas like immunoassay and infectious disease testing. Partnerships with entities including Abbott and Northwell Health have been formed to distribute these solutions. Resources, including webinars and educational materials, are made available through the Knowledge Centre. Operations are conducted from locations in Ireland and the USA, focusing on meeting regulatory standards in diagnostics.
Technopath Clinical Diagnostics offers Multichem QC and IAMQC Solutions.
Technopath Clinical Diagnostics operates through Technopath Clinical Diagnostics.
Yes. Technopath Clinical Diagnostics was acquired by LGC in February 2021.